4

$PFE · Pfizer Inc.

October 14, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

Pfizer filed a Form 4 with the SEC on October 14, 2026, reporting a change in beneficial ownership for Albert Bourla, the company’s Chairman and CEO. The filing covers a transaction dated October 13, 2026, in which Bourla acquired 71 phantom stock units under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan. Each unit represents one phantom share of Pfizer common stock, and the units were valued at $28.37 per unit.

The phantom stock units are settled in cash following Bourla’s separation from service, and he may transfer them into an alternative investment account at any time. After the reported transaction, Bourla beneficially owned 783,981 phantom stock units directly. The filing does not report any acquisition or disposal of actual Pfizer common stock, and it does not describe any open-market purchase or sale.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →